These findings support the hypothesis of a dual-pathogenesis model in EGPA, whereby eosinophilic inflammation drives asthma, chronic rhinosinusitis, and eosinophil-mediated organ damage, while MPO-ANCA mediates vasculitic manifestations. The gene discussed is MPO; the disease is inflammatory response.